UAE grants emergency approval for Sinopharm COVID-19 vaccine

United Arab Emirates // 15 September, 2020

The United Arab Emirates (UAE) has granted emergency approval for an inactivated coronavirus vaccine developed in China to be provided to healthcare workers.

The approval comes six weeks after Phase 3 testing of the vaccine began in the UAE and has not been completed. The vaccine has been tested on 31,000 volunteers and so far, only mild and expected side-effects have been reported.

The vaccine passed Phase 1 & 2 trials in the UAE with 100% of volunteers generating antibodies after two doses 28 days apart. The trials were jointly operated by G42 Healthcare, a local AI company, and the Chinese company Sinopharm. Phase 3 trials of the vaccine are also underway in Peru and Morocco.

Note that Sinopharm have two inactivated virus vaccines in development and that these are different to the “Sinovac” vaccine being developed by the Chinese company “Sinovac Biotech”.

LATEST NEWS

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
Webinars

Pandemic Information Webinars
(Available to Pandemic Subscribers only)
Register for upcoming events
View/Download previous webinars